[go: up one dir, main page]

DK336487A - Krystallinsk hydrat af oralt cephalosporin og praeparat deraf - Google Patents

Krystallinsk hydrat af oralt cephalosporin og praeparat deraf

Info

Publication number
DK336487A
DK336487A DK336487A DK336487A DK336487A DK 336487 A DK336487 A DK 336487A DK 336487 A DK336487 A DK 336487A DK 336487 A DK336487 A DK 336487A DK 336487 A DK336487 A DK 336487A
Authority
DK
Denmark
Prior art keywords
crystallinic
hydrate
preparations
oral cephalosporin
cephalosporin
Prior art date
Application number
DK336487A
Other languages
English (en)
Other versions
DK161080C (da
DK336487D0 (da
DK161080B (da
Inventor
Yoshio Hamashima
Kyoji Minami
Kyozo Kawata
Teruo Sakamoto
Toyohiko Takeda
Yusuke Suzuki
Masanori Tujikawa
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP61156954A external-priority patent/JP2544113B2/ja
Priority claimed from JP21626086A external-priority patent/JPH0717651B2/ja
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of DK336487D0 publication Critical patent/DK336487D0/da
Publication of DK336487A publication Critical patent/DK336487A/da
Publication of DK161080B publication Critical patent/DK161080B/da
Application granted granted Critical
Publication of DK161080C publication Critical patent/DK161080C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
DK336487A 1986-07-02 1987-06-30 Krystallinsk hydrat af oralt anvendeligt cephalosporin og praeparat dermed DK161080C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP15695486 1986-07-02
JP61156954A JP2544113B2 (ja) 1986-07-02 1986-07-02 安定なカプセル製剤
JP21626086A JPH0717651B2 (ja) 1986-09-12 1986-09-12 経口投与用セフアロスポリン水和物結晶
JP21626086 1986-09-12

Publications (4)

Publication Number Publication Date
DK336487D0 DK336487D0 (da) 1987-06-30
DK336487A true DK336487A (da) 1988-01-03
DK161080B DK161080B (da) 1991-05-27
DK161080C DK161080C (da) 1991-11-11

Family

ID=26484565

Family Applications (1)

Application Number Title Priority Date Filing Date
DK336487A DK161080C (da) 1986-07-02 1987-06-30 Krystallinsk hydrat af oralt anvendeligt cephalosporin og praeparat dermed

Country Status (27)

Country Link
US (2) US4812561A (da)
KR (1) KR950005302B1 (da)
CN (1) CN1015106B (da)
AR (1) AR243893A1 (da)
AT (1) AT392472B (da)
AU (1) AU594167B2 (da)
BE (1) BE1001691A4 (da)
CA (1) CA1283405C (da)
CH (1) CH672788A5 (da)
DE (1) DE3721913A1 (da)
DK (1) DK161080C (da)
ES (2) ES2004952A6 (da)
FI (1) FI89052C (da)
FR (1) FR2601014B1 (da)
GB (1) GB2192183B (da)
GR (1) GR871014B (da)
HK (1) HK47893A (da)
HU (1) HU200777B (da)
IE (1) IE59613B1 (da)
IL (1) IL83059A (da)
IT (1) IT1211469B (da)
NL (1) NL193136C (da)
NO (1) NO170889C (da)
NZ (1) NZ220764A (da)
PL (1) PL159180B1 (da)
RU (1) RU1829932C (da)
SE (1) SE466257B (da)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089270A (en) * 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
US5599557A (en) * 1992-04-30 1997-02-04 Schering Corporation Stable hydrated cephalosporin dry powder for oral suspension formulation
WO2000024790A2 (en) * 1998-10-27 2000-05-04 Eastman Chemical Company Process for the polymerization of olefins; polyethylenes, a nd films and articles produced therefrom
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
AT412213B (de) * 2000-05-30 2004-11-25 Sandoz Ag Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
JP2006528185A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004258949B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005009368A2 (en) * 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005016311A1 (en) * 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
WO2005016278A2 (en) 2003-08-12 2005-02-24 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
JP5686494B2 (ja) * 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
AU2004273830B2 (en) * 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2007517039A (ja) * 2003-12-24 2007-06-28 アドバンシス ファーマスーティカル コーポレイション 変性放出製剤の吸収増強
EP1771158A4 (en) * 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp TABLET FOR PULSE DISTRIBUTION
US20110104109A1 (en) * 2005-07-13 2011-05-05 Frank Bennett Tetracyclic indole derivatives and their use for treating or preventing viral infections
WO2007054550A1 (en) 2005-11-11 2007-05-18 Boehringer Ingelheim International Gmbh Quinazoline derivatives for the treatment of cancer diseases
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
AR062927A1 (es) * 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
CA2673254C (en) * 2006-12-22 2013-09-10 Schering Corporation 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
AU2007339382B2 (en) 2006-12-22 2013-05-02 Merck Sharp & Dohme Llc 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
JP5055377B2 (ja) 2006-12-22 2012-10-24 シェーリング コーポレイション [5,6−環]環形成インドール誘導体およびその使用方法
WO2009032125A1 (en) * 2007-08-29 2009-03-12 Schering Corporation 2,3-substituted azaindole derivatives for treating viral infections
JP5272008B2 (ja) * 2007-08-29 2013-08-28 メルク・シャープ・アンド・ドーム・コーポレーション 置換インドール誘導体およびその使用の方法
RU2010111550A (ru) * 2007-08-29 2011-10-10 Шеринг Корпорейшн (US) 2,3-замещенные индольные производные для лечения вирусных инфекций
JP5416708B2 (ja) * 2007-11-16 2014-02-12 メルク・シャープ・アンド・ドーム・コーポレーション 3−アミノスルホニル置換インドール誘導体およびそれらの使用方法
US8765757B2 (en) * 2007-11-16 2014-07-01 Merck Sharp & Dohme Corp. 3-heterocyclic substituted indole derivatives and methods of use thereof
AR072088A1 (es) * 2008-06-13 2010-08-04 Schering Corp Derivados de indol triciclicos y sus metodos de uso
WO2010022128A1 (en) 2008-08-20 2010-02-25 Schering Corporation Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
AR072938A1 (es) 2008-08-20 2010-09-29 Southern Res Inst Derivados de piridina y pirimidina azosustituidos y su uso en el tratamiento de infecciones virales
TW201020245A (en) 2008-08-20 2010-06-01 Schering Corp Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
US8697694B2 (en) 2008-08-20 2014-04-15 Merck Sharp & Dohme Corp. Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
US8980920B2 (en) 2009-05-29 2015-03-17 Merck Sharp & Dohme Corp. Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis C
PT2451445T (pt) 2009-07-06 2019-07-10 Boehringer Ingelheim Int Processo para secagem de bibw2992, dos seus sais e de formulações farmacêuticas sólidas compreendendo este ingrediente ativo
US20120276047A1 (en) 2009-11-25 2012-11-01 Rosenblum Stuart B Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
WO2011087740A1 (en) 2009-12-22 2011-07-21 Schering Corporation Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
EP2536410B1 (en) 2010-02-18 2015-09-23 Merck Sharp & Dohme Corp. Substituted pyrimidine derivatives and their use in treating viral infections
EP2545060B1 (en) 2010-03-09 2015-11-25 Merck Sharp & Dohme Corp. Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases
WO2011139253A2 (en) 2010-05-04 2011-11-10 Mahmut Bilgic Pharmaceutical compositions comprising ceftibuten
EP2598149A4 (en) 2010-07-26 2014-09-10 Merck Sharp & Dohme SUBSTITUTED BIPHENYLENE COMPOUNDS AND METHOD FOR USE THEREOF FOR THE TREATMENT OF VIRUS DISEASES
JP2013540122A (ja) 2010-09-29 2013-10-31 メルク・シャープ・エンド・ドーム・コーポレイション 縮合四環式化合物誘導体およびウィルス疾患治療のためのそれの使用方法
EP2696681B1 (en) 2011-04-13 2018-10-03 Merck Sharp & Dohme Corp. 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
EP2697242B1 (en) 2011-04-13 2018-10-03 Merck Sharp & Dohme Corp. 2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
WO2013033899A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
WO2013033900A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
WO2013033901A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
WO2013039876A1 (en) 2011-09-14 2013-03-21 Merck Sharp & Dohme Corp. Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
WO2013151518A1 (en) * 2012-04-04 2013-10-10 Mahmut Bilgic Capsule formulations comprising ceftibuten
EP2815743A1 (en) 2013-06-21 2014-12-24 Sanovel Ilac Sanayi ve Ticaret A.S. Ceftibuten formulations
WO2015065817A1 (en) 2013-10-30 2015-05-07 Merck Sharp & Dohme Corp. Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof
US9242965B2 (en) 2013-12-31 2016-01-26 Boehringer Ingelheim International Gmbh Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
CN103948932B (zh) * 2014-04-17 2016-03-16 海南日中天制药有限公司 一种头孢克肟组合物及其制备方法
EP3031450A1 (en) 2014-12-12 2016-06-15 Sanovel Ilac Sanayi ve Ticaret A.S. Ceftibuten capsule compositions
AU2017261828B2 (en) 2016-05-13 2023-04-13 Aeromics, Inc. Crystals
EP3478693B1 (en) 2016-06-30 2021-07-21 Qpex Biopharma, Inc. Boronic acid derivatives and therapeutic uses thereof
CN106397454B (zh) * 2016-08-30 2018-08-24 山东罗欣药业集团股份有限公司 一种抗感染药物头孢布烯晶型化合物及其组合物
CN106432270A (zh) * 2016-09-21 2017-02-22 临沂草之美医药科技有限公司 一种制备治疗外科手术感染的药物头孢布烯晶体化合物的方法
CN106397457A (zh) * 2016-09-21 2017-02-15 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢布烯晶体化合物
CN106432271A (zh) * 2016-09-21 2017-02-22 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢布烯晶体化合物
CN106432272A (zh) * 2016-09-21 2017-02-22 临沂草之美医药科技有限公司 一种制备治疗外科手术感染的药物头孢布烯晶体化合物的方法
EP4362950A4 (en) * 2021-07-01 2025-08-13 Qpex Biopharma Inc CRYSTALLINE FORMS OF CEFTIBUTEN

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819620A (en) * 1972-06-01 1974-06-25 Squibb & Sons Inc 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate
JPS5726692A (en) * 1980-07-22 1982-02-12 Fujisawa Pharmaceut Co Ltd Preparation of stable crystal of salt of ceftizoxime
DE3037997A1 (de) * 1980-10-08 1982-05-13 Bayer Ag (beta) -lactamantibiotika, verfahren zu deren herstellung sowie sie enthaltende mittel
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
AU575854B2 (en) * 1983-10-04 1988-08-11 Shionogi & Co., Ltd. 7beta-(carboxyalkenamido) cephalosporins
AU580855B2 (en) * 1985-03-29 1989-02-02 Shionogi & Co., Ltd. Alkeneamidocephalosporin esters

Also Published As

Publication number Publication date
IT8767566A0 (it) 1987-07-01
CA1283405C (en) 1991-04-23
US4812561A (en) 1989-03-14
US4933443A (en) 1990-06-12
DK161080C (da) 1991-11-11
IT1211469B (it) 1989-11-03
DE3721913A1 (de) 1988-01-07
SE8702705D0 (sv) 1987-06-30
PL159180B1 (pl) 1992-11-30
IE59613B1 (en) 1994-03-09
KR880001670A (ko) 1988-04-26
BE1001691A4 (fr) 1990-02-13
GR871014B (en) 1987-11-02
AR243893A1 (es) 1993-09-30
SE8702705L (sv) 1988-01-03
FI89052C (fi) 1993-08-10
HUT44257A (en) 1988-02-29
GB2192183A (en) 1988-01-06
PL266567A1 (en) 1988-07-21
NO872729L (no) 1988-01-04
DK336487D0 (da) 1987-06-30
NO872729D0 (no) 1987-06-30
FR2601014B1 (fr) 1990-09-14
RU1829932C (ru) 1993-07-23
GB2192183B (en) 1990-05-16
FI89052B (fi) 1993-04-30
NL193136C (nl) 1998-12-04
HU200777B (en) 1990-08-28
FI872903A0 (fi) 1987-07-01
NZ220764A (en) 1989-09-27
GB8715064D0 (en) 1987-08-05
AT392472B (de) 1991-04-10
SE466257B (sv) 1992-01-20
FR2601014A1 (fr) 1988-01-08
ATA165887A (de) 1990-09-15
NO170889B (no) 1992-09-14
CN87105009A (zh) 1988-03-23
NO170889C (no) 1992-12-23
IL83059A (en) 1992-03-29
ES2008759A6 (es) 1989-08-01
IE871738L (en) 1988-01-02
NL8701507A (nl) 1988-02-01
CH672788A5 (da) 1989-12-29
KR950005302B1 (ko) 1995-05-23
CN1015106B (zh) 1991-12-18
NL193136B (nl) 1998-08-03
IL83059A0 (en) 1987-12-31
HK47893A (en) 1993-05-27
ES2004952A6 (es) 1989-02-16
AU7504087A (en) 1988-01-07
AU594167B2 (en) 1990-03-01
DK161080B (da) 1991-05-27
FI872903L (fi) 1988-01-03

Similar Documents

Publication Publication Date Title
DK336487D0 (da) Krystallinsk hydrat af oralt cephalosporin og praeparat deraf
DK33287D0 (da) Imidazolanaloge af mevalonolacton og derivater deraf
DK170187A (da) Pharmaceutisk fordelagtigt salt af amlodipin og farmaceutiske praeparater indeholdende dette
NO170421C (no) Fremgangsmaate for ekstraksjon og opprensing av proteiner
DK237187D0 (da) Farmaceutisk anvendelse af t-pa
NO875232D0 (no) Stabile preparater av ricin-toksin-a-kjede og av rta-immunokonjugater og stabilisator-utsorteringsmetoder derav.
DK363887D0 (da) Anvendelse af bromcruptin
DK114687A (da) Anvendelse af diphenylhydantoin og derivater deraf
DK273089D0 (da) Anvendelse af peptidderivater
DK549087A (da) Gangliosidbeslaegtede forbindelser og fremgangsmaade til fremstilling af samme
DK448887A (da) Hidtil ukendt amylaseenzym og fremgangsmaade til fremstilling af samme
DK119688D0 (da) 23-oxo- (-keto-) og 23-imino-derivater af mono- og diepoxy-ll-f28249-forbindelser
DK87888D0 (da) Terapeutisk anvendelse af tindijoddeuteroporfyrin
KR890001841A (ko) 캔의 용이 개봉 단부
DK449188A (da) 2'-deoxy-5-fluoruridinderivater og farmaceutiske praeparater med indhold af saadanne forbindelser
DK446388D0 (da) Pyrazinoxidforbindelse af nf-1616 -904 og farmaceutisk praeparat indeholdende denne
DK127187A (da) Farmaceutisk kombination af t-pa og oxypurinol
TR23973A (tr) Feniltio uereler fenilnoti uereler ve fenil karbodi- imidler bunlarin elde edilmeleri
DK335386A (da) Embonater af quinoloncarboxylsyrer og derivater deraf
NO861083L (no) Analogifremgangsmaate og fremstilling av imidazoisokinoliner og imidazo-tienopyridin-forbindelser.
DK119488D0 (da) Mono- og diepoxidderivater af 23-deoxy-ll-f28249-forbindelser
DK135387D0 (da) Fremstilling af proteiner
NO165155C (no) Framgangsmaate for bygging og demontering av bygningsdeler.
DK75691A (da) Ny farmaceutisk anvendelse af fusidin og derivater deraf
DK324187A (da) Herbicidt praeparat indeholdende ureaderivater og en modgift

Legal Events

Date Code Title Description
PUP Patent expired